{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:03Z","timestamp":1786118943040,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/olq.0b013e31815ea8d1","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T03:02:32Z","timestamp":1205895752000},"page":"346-351","source":"Crossref","is-referenced-by-count":25,"title":["Optimal Frequency of Imiquimod (Aldara) 5% Cream for the Treatment of External Genital Warts in Immunocompetent Adults: A Meta-Analysis"],"prefix":"10.1097","volume":"35","author":[{"given":"Elena P.","family":"Gotovtseva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha S.","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Smolensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lairson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210213","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients.","volume":"37","author":"Brown","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"R2-5-20210213","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.vaccine.2005.09.002","article-title":"Immune responses to human papillomavirus.","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"key":"R3-5-20210213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00007435-200203000-00001","article-title":"Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls.","volume":"29","author":"De Panfilis","year":"2002","journal-title":"Sex Transm Dis"},{"issue":"5A","key":"R4-5-20210213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection.","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"key":"R5-5-20210213","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States.","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R6-5-20210213","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/0956462981921143","article-title":"An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle.","volume":"9","author":"Maw","year":"1998","journal-title":"Int J STD AIDS"},{"key":"R7-5-20210213","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00019053-200523110-00004","article-title":"Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: Analytic framework and review of the literature.","volume":"23","author":"Insinga","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"R8-5-20210213","first-page":"333","article-title":"Warts: A guide to their removal.","volume":"46","author":"Scheinfeld","year":"2006","journal-title":"Consultant"},{"key":"R9-5-20210213","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1258\/095646204774195173","article-title":"Critical appraisal of commonly used treatment for genital warts.","volume":"15","author":"Maw","year":"2004","journal-title":"Int J STD AIDS"},{"issue":"1","key":"R10-5-20210213","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1067\/mjd.2000.107808","article-title":"Immunomodulatory and pharmacologic properties of imiquimod.","volume":"43","author":"Sauder","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R11-5-20210213","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/B:APPT.0000025805.55340.c3","article-title":"Immune modulation and apoptosis induction: Two sides of the antitumoral activity of imiquimod.","volume":"9","author":"Schon","year":"2004","journal-title":"Apoptosis"},{"key":"R12-5-20210213","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0166-3542(99)00033-9","article-title":"Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%.","volume":"43","author":"Arany","year":"1999","journal-title":"Antiviral Res"},{"key":"R13-5-20210213","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts. HPV study group.","volume":"134","author":"Edwards","year":"1998","journal-title":"Human Papillomavirus Arch Dermatol"},{"key":"R14-5-20210213","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/095646240101200105","article-title":"Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.","volume":"12","author":"Gollnick","year":"2001","journal-title":"Int J STD AIDS"},{"key":"R15-5-20210213","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1258\/0956462011924218","article-title":"Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts\u2013results of an open-label, multicentre phase IIIB trial.","volume":"12","author":"Garland","year":"2001","journal-title":"Int J STD AIDS"},{"key":"R16-5-20210213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2334-1-3","article-title":"Imiquimod for the treatment of genital warts: A quantitative systematic review.","volume":"1","author":"Moore","year":"2001","journal-title":"BMC Infect Dis"},{"key":"R18-5-20210213","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00007435-200104000-00007","article-title":"Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.","volume":"28","author":"Fife","year":"2001","journal-title":"Sex Transm Dis"},{"key":"R19-5-20210213","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0020-7292(01)00573-2","article-title":"Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women.","volume":"76","author":"Trofatter","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"R20-5-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"R21-5-20210213","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2105\/AJPH.92.10.1619","article-title":"Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: A meta-analysis of randomized, controlled trials.","volume":"92","author":"McCulloch","year":"2002","journal-title":"Am J Public Health"},{"key":"R22-5-20210213","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S0266462300008916","article-title":"Some statistical methods for combining experimental results.","volume":"6","author":"Laird","year":"1990","journal-title":"Int J Technol Assess Health Care"},{"key":"R23-5-20210213","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.42.4.789","article-title":"Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.","volume":"42","author":"Beutner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-5-20210213","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1258\/095646206777689161","article-title":"An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.","volume":"17","author":"Garland","year":"2006","journal-title":"Int J STD AIDS"},{"key":"R25-5-20210213","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1258\/095646203321043192","article-title":"ESCCRIM g. Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts.","volume":"14","author":"Vilata","year":"2003","journal-title":"Int J STD AIDS"},{"key":"R26-5-20210213","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1468-3083.2004.00918.x","article-title":"Closing the feedback loop: An audit of the use of imiquimod for the treatment of genital warts.","volume":"18","author":"Brady","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R27-5-20210213","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/thorax.57.1.20","article-title":"Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: A systematic review.","volume":"57","author":"Clegg","year":"2002","journal-title":"Thorax"},{"key":"R28-5-20210213","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/nur.10092","article-title":"Research methods: Managing primary study quality in meta-analyses.","volume":"26","author":"Conn","year":"2003","journal-title":"Res Nurs Health"},{"key":"R29-5-20210213","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00007435-200302000-00006","article-title":"Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.","volume":"30","author":"Sauder","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R30-5-20210213","article-title":"Meta-Analysis, Decision-Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine.","author":"Petitti","year":"2000"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007435-200804000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:59:59Z","timestamp":1786035599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-200804000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e31815ea8d1","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}